Skip to the page

Data / Form D filings / Protean Biodiagnostics Inc.

Protean Biodiagnostics Inc.: Form D filings

Protean Biodiagnostics Inc., a health care company in Orlando, FL, filed 5 Form D notices with the SEC between 2019 and 2023. The latest, on December 7, 2023, reports an offering of $6 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6555 SANGER ROAD, SUITE 232, Orlando, FL, 32827
Phone
(754) 242-9682
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Florida
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1776193

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 7, 2023New notice$6,000,000$0$6,000,0000Yet to occursec.gov
May 18, 2021New notice$1,724,250$1,429,500$294,75012Yet to occursec.gov
May 14, 2021Amendment$1,500,000$0$1,500,0000Yet to occursec.gov
Jan 4, 2021New notice$1,500,000$0$1,500,0000Yet to occursec.gov
Jun 27, 2019New notice$800,000$330,000$470,0004Jun 4, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ronen Martin IsraelDirector
Frank Martin MorsaniDirector
Susan Martin LeeExecutive Officer
Anees Martin ChagparDirector
Violet Martin JamesonDirector
Anthony Martin MaglioccoExecutive Officer, Director

Other health care companies in Florida that filed recently

Every Form D from the week of Dec 4, 2023 · All recent filings in Florida · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Protean Biodiagnostics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.